Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients

This single‐centre retrospective observational study analysed the efficacy of retreatment with immunomodulatory agents (IMiDs) and proteasome inhibitors (PIs) after treatment with daratumumab monotherapy in patients with relapsed and/or refractory multiple myeloma (RRMM). In total 55 patients were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oostvogels, Rimke, Jak, Margot, Raymakers, Reinier, Mous, Rogier, Minnema, Monique C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220946/
https://www.ncbi.nlm.nih.gov/pubmed/30080247
http://dx.doi.org/10.1111/bjh.15504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220946/
https://www.ncbi.nlm.nih.gov/pubmed/30080247
http://dx.doi.org/10.1111/bjh.15504

Ejemplares similares